![William Mezzanotte](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William Mezzanotte
Direttore Tecnico/Scientifico/R&S presso CSL LIMITED
Posizioni attive di William Mezzanotte
Società | Posizione | Inizio | Fine |
---|---|---|---|
CSL LIMITED | Direttore Tecnico/Scientifico/R&S | 01/10/2018 | - |
Ufficiale delle Risorse Umane | 01/10/2018 | - | |
University City Science Center
![]() University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | Direttore/Membro del Consiglio | 19/06/2020 | - |
Storia della carriera di William Mezzanotte
Precedenti posizioni note di William Mezzanotte
Società | Posizione | Inizio | Fine |
---|---|---|---|
BELLUS HEALTH | Direttore/Membro del Consiglio | 24/03/2021 | 01/01/2023 |
C.H. Boehringer Sohn AG & Co. KG
![]() C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Corporate Officer/Principal | 01/04/2015 | 01/04/2017 |
ASTRAZENECA PLC | Corporate Officer/Principal | 01/06/2012 | 01/03/2015 |
CSL Behring LLC
![]() CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Direttore Tecnico/Scientifico/R&S | 01/04/2017 | - |
Corporate Officer/Principal | - | - |
Formazione di William Mezzanotte
Villanova University | Undergraduate Degree |
University of Pennsylvania | Doctorate Degree |
The Johns Hopkins University | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Regno Unito | 2 |
Australia | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Director/Board Member | 2 |
Settori
Health Technology | 6 |
Consumer Services | 4 |
Miscellaneous | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
ASTRAZENECA PLC | Health Technology |
CSL LIMITED | Health Technology |
Aziende private | 4 |
---|---|
C.H. Boehringer Sohn AG & Co. KG
![]() C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
University City Science Center
![]() University City Science Center Investment Trusts/Mutual FundsMiscellaneous University City Science Center provides physical space, resources and other support to the community. The company was founded in 1963 and is headquartered in Philadelphia, PA. | Miscellaneous |
BELLUS Health, Inc.
![]() BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
CSL Behring LLC
![]() CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
- Borsa valori
- Insiders
- William Mezzanotte
- Esperienza